New treatment modalities for neovascular age-related macular degeneration

Age-related macular degeneration (AMD) is considered one of the main causes of severe vision loss in older adults. The neovascular form (nAMD) is an advanced stage, which is responsible for the most severe vision loss. Vascular endothelial growth factor (VEGF) is at present the main factor that lead...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2017

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/23066

Acceso en línea:

https://doi.org/10.22608/APO.2017258
https://repository.urosario.edu.co/handle/10336/23066

Palabra clave:

Angiogenesis inhibitor
Monoclonal antibody
Platelet derived growth factor
Vasculotropin
Antagonists and inhibitors
Clinical trial (topic)
Gene therapy
Human
Macular degeneration
Procedures
Subretinal neovascularization
Angiogenesis inhibitors
Choroidal neovascularization
Clinical trials as topic
Genetic therapy
Humans
Macular degeneration
Platelet-derived growth factor
Vascular endothelial growth factors
Amd
Neovascular
New
Treatment
Vegf
monoclonal
Antibodies

Rights

License

Abierto (Texto Completo)